Last reviewed · How we verify
NCT05611307
Late Subclinical Cardiovascular Disease in Testicular Cancer Survivors
trial testing Lipid profile in Testicular Cancer in 31 participants. Terminated before completion.
4 December 2024
Quick facts
| Lead sponsor | Indiana University |
|---|---|
| Status | Terminated |
| Study type | OBSERVATIONAL |
| Enrollment | 31 |
| Start date | 11 October 2022 |
| Primary completion | 4 December 2024 |
| Estimated completion | 4 December 2024 |
| Sites | 1 location across United States |
Drugs / interventions tested
- Lipid profile
- Coronary artery assessment
- Hormone levels for hypogonadism
Conditions studied
- Testicular Cancer — all drugs for Testicular Cancer →
- Survivorship — all drugs for Survivorship →
- ASCVD — all drugs for ASCVD →
- Coronary Artery Disease — all drugs for Coronary Artery Disease →
Sponsor
Indiana University
Who can join
Adults 18 to 99, male only, with Testicular Cancer or Survivorship. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Late subclinical cardiovascular disease in testicular cancer survivors exposed to cisplatin-based chemotherapy and bone marrow transplant
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT05611307
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Lipid profile
Trials testing the same drug.
- NCT06067399 — Relationship Between Red Cell Distribution Width (RDW) and HbA1C in Patients With Type 2 Diabetes Mellitus After Glycemi · recruiting
- NCT06402305 — Lipid Profile and Ultrasound Findings in Patients With Pancreaticobiliary Diseases · recruiting
Other recruiting trials for Testicular Cancer
Currently open trials in the same condition.
- NCT07498959 — Primary RPLND Versus Systemic Chemotherapy in Good-prognosis Metastatic Testicular Cancer · NA · recruiting
- NCT07124000 — DESTINY-PANTUMOUR04 · recruiting
- NCT07106827 — A Study of GV20-0251 in Advanced or Refractory Solid Tumors · Phase 1 · recruiting
- NCT07228637 — Pursuing Exploration Into the Supportive Care Needs and Intervention Preferences of Survivors of Testicular Cancer · NA · active not recruiting
- NCT06932458 — A Clinical Trial of Primary Retroperitoneal Lymph Node Dissection in Patients With Testicular Seminoma With Limited Retr · Phase 2 · recruiting
Other Indiana University trials
Trials by the same sponsor.
- NCT07470086 — The Role of Environmental Temperatures in Respiratory Control · NA · not yet recruiting
- NCT07470099 — The Role of Breathing Perception in Respiratory Control · NA · not yet recruiting
- NCT07179952 — Efficacy and Safety of Slow Release Dehydroepiandrosterone (DHEA ) · Phase 2 · not yet recruiting
- NCT07070804 — Maternal Biomarkers and Environmental Contributors to Autism Spectrum Disorders in Children of First-time Mothers · not yet recruiting
- NCT07499583 — Psilocybin Assisted Psychotherapy for Treatment Resistant Depression and Co-occurring Substance Use Disorder · Phase 1, PHASE2 · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05611307 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Indiana University
- Last refreshed: 11 August 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05611307.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing